19-51025642-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_144947.3(KLK11):c.86C>T(p.Pro29Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,585,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144947.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLK11 | NM_001136032.3 | c.-11C>T | 5_prime_UTR_variant | 2/6 | ENST00000453757.8 | NP_001129504.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLK11 | ENST00000453757.8 | c.-11C>T | 5_prime_UTR_variant | 2/6 | 1 | NM_001136032.3 | ENSP00000413958.2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152140Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000123 AC: 26AN: 210588Hom.: 0 AF XY: 0.000158 AC XY: 18AN XY: 113902
GnomAD4 exome AF: 0.000161 AC: 231AN: 1433240Hom.: 0 Cov.: 30 AF XY: 0.000167 AC XY: 119AN XY: 711186
GnomAD4 genome AF: 0.000105 AC: 16AN: 152140Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74322
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.86C>T (p.P29L) alteration is located in exon 2 (coding exon 2) of the KLK11 gene. This alteration results from a C to T substitution at nucleotide position 86, causing the proline (P) at amino acid position 29 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at